Found 6 matching trials
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors
PHASE4Inhibition of dipeptidyl peptidase-4 (DPP-4) or sodium-glucose co-transport...
Location
Kurume University Hospital
Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus
N/AThe purpose of this study is to integrate the post-marketing surveillances ...
Location
Multiple Locations
SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD
PHASE4The clinicopathological analyses revealed that reduction in HbA1c and use o...
Location
Kanazawa University Graduate School of Medical Sciences
TOFO Insulin Combination Trial
PHASE4Primary Objectives:
To assess the effects of tofogliflozin on glycemic con...
Location
Investigational Site Number 392-028
Tofogliflozin GLP-1 Analogue Combination Trial
PHASE4An open-label, multicenter study to evaluate 52-week long-term safety, tole...
Location
Multiple Locations
Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)
PHASE2This multicenter, randomized, open-label, controlled study will assess the ...
Location
Shinshu University